title: Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma.
authors.affiliation: Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Penvadee
authors.initials: P
authors.lastname: Pattanaprichakul
authors.forename: Michael T
authors.initials: MT
authors.lastname: Tetzlaff
authors.forename: Whitney J
authors.initials: WJ
authors.lastname: Lapolla
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Torres-Cabala
authors.forename: Madeleine
authors.initials: M
authors.lastname: Duvic
authors.forename: Victor G
authors.initials: VG
authors.lastname: Prieto
authors.forename: Kenneth Y
authors.initials: KY
authors.lastname: Tsai
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Curry
mesh_terms: D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology*; D015434:Panniculitis / Q000139:chemically induced* / Q000473:pathology*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D007211:Indoles; D013449:Sulfonamides
keywords: neutrophilic dermatosis; toxicity; vemurafenib